BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. QQQ

Go back to BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint
BIOLIFE SOLUTIONS (NASDAQ: BLFS) Delayed: 38.49 -0.09 (0.23%)
Previous Close $38.58    52 Week High $3.58 
Open $38.51    52 Week Low $1.43 
Day High $38.68    P/E N/A 
Day Low $38.12    EPS $0.00 
Volume 947,486       

Intelligroup, Inc. (NASDAQ: TIG) Delayed: 6.16 --0 (-0%)
Previous Close $6.16    52 Week High $0.09 
Open $0.03    52 Week Low $0.03 
Day High $6.16    P/E N/A 
Day Low $6.16    EPS $-0.16 
Volume 1,500